Insider trading

Period: 120 months Stock: CUE Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

66 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

66 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

66 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

66 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
66 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
66 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

66 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Aug 2026
Lin Shao-Lee Chief Executive Officer
Sold at will 3×
$522.57K 18,258 at 28.62
2.5%
Not planned
13 Aug 2026
Ray Sumita Chief Legal Compliance Officer
Sold at will 3×
$265.63K 8,829 at 30.09
6.9%
Not planned
13 Aug 2026
Meluzio Michael Vincent VP, Prin. Accounting Officer
Sold at will 3×
$169.32K 5,628 at 30.09
10.3%
Not planned
12 Aug 2026
Lin Shao-Lee Chief Executive Officer
Sold at will 2×
$1.08M 40,000 at 27.10
5.2%
Not planned
30 Dec 2025
Sarraf Pasha Director
Bought 5×
$99.75K 323,857 at 0.31
opened
First buy on file
16 Dec 2024
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER
Bought
$30.90K 30,000 at 1.03
22.3%
Largest buy in 3 yrs
25 Aug 2023
Suri Anish PRESIDENT AND CSO
Bought
$11.04K 4,000 at 2.76
3.0%
First buy on file
14 Aug 2023
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER
Bought
$8.58K 3,000 at 2.86
2.3%
23 Mar 2023
Kiener Peter A Director
Sold at will
$30.59K 9,325 at 3.28
96.3%
Sold half or more
27 May 2022
Morich Frank Director
Bought
$105.00K 28,000 at 3.75
opened
First buy on file
24 May 2022
Fletcher Aaron G.L. Director · indirect
Bought
$183.70K 55,000 at 3.34
6.2%
23 May 2022
Fletcher Aaron G.L. Director · indirect
Bought
$528.00K 150,000 at 3.52
20.4%
+20% of stake
31 Mar 2022
Fletcher Aaron G.L. Director · indirect
Bought
$3.50M 735,000 at 4.76
opened
Largest buy in 3 yrs
16 Nov 2021
Kiener Peter A Director
Sold, plan not stated
$24.53K 1,361 at 18.02
100%
Sold half or more
15 Nov 2021
Kiener Peter A Director
Sold, plan not stated
$337.16K 18,815 at 17.92
100%
Sold half or more
15 Nov 2021
Suri Anish President and CSO
Sold, plan not stated
$144.40K 8,000 at 18.05
7.8%
11 Nov 2021
Suri Anish President and CSO
Sold, plan not stated
$301.35K 20,000 at 15.07
17.5%
1 Oct 2021
Millar Kerri-Ann CHIEF FINANCIAL OFFICER
Sold, plan not stated
$17.78K 1,251 at 14.21
10.7%
24 Sep 2021
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER
Bought
$50.05K 3,400 at 14.72
6.5%
First buy on file
23 Sep 2021
Suri Anish PRESIDENT AND CSO
Sold, plan not stated
$304.65K 20,000 at 15.23
21.1%
16 Mar 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$6.63K 439 at 15.09
18.0%
15 Mar 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$196.27K 13,000 at 15.10
86.7%
Sold half or more
17 Feb 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$64.35K 4,274 at 15.06
68.1%
Sold half or more
16 Feb 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$242.42K 16,000 at 15.15
88.9%
Sold half or more
20 Jan 2021
Pienta Kenneth Chief Medical Officer
Bought
$40.98K 2,720 at 15.07
136%
First buy on file
24 Nov 2020
Bought
$82.78K 6,548 at 12.64
4.1%
First buy on file
30 Sep 2020
Gray Cameron Director
Bought
$76.50K 5,000 at 15.30
0.7%
First buy on file
29 Sep 2020
Gray Cameron Director
Bought
$75.00K 5,000 at 15.00
0.7%
First buy on file
5 Aug 2020
Sandercock Colin SVP, General Counsel and Sec
Sold, plan not stated
$265.48K 13,274 at 20.00
43.7%
5 Aug 2020
Suri Anish President and CSO
Sold, plan not stated
$16.01K 800 at 20.01
2.3%
4 Aug 2020
Suri Anish President and CSO
Sold, plan not stated
$8.06K 400 at 20.14
1.1%
4 Aug 2020
Sandercock Colin SVP, General Counsel and Sec
Sold, plan not stated
$4.03K 201 at 20.05
1.2%
3 Aug 2020
Sandercock Colin SVP, General Counsel and Sec
Sold, plan not stated
$128.50K 6,425 at 20.00
27.3%
3 Aug 2020
Suri Anish President and CSO
Sold, plan not stated
$116.06K 5,800 at 20.01
14.4%
24 Jun 2020
Bought 2×
$186.57K 7,500 at 24.88
5.0%
First buy on file
31 Dec 2019
Sold, plan not stated
$141.39K 9,000 at 15.71
100%
Sold half or more
31 Dec 2019
MARLETT CHRISTOPHER A Director · indirect
Sold, plan not stated
$105.66K 6,700 at 15.77
0.9%
27 Dec 2019
MARLETT CHRISTOPHER A Director · indirect
Sold, plan not stated
$155.16K 9,000 at 17.24
1.1%
26 Dec 2019
MARLETT CHRISTOPHER A Director · indirect
Sold, plan not stated
$344.41K 19,647 at 17.53
2.4%
23 Dec 2019
MARLETT CHRISTOPHER A Director · indirect
Sold, plan not stated
$285.94K 17,000 at 16.82
2.1%
19 Dec 2019
MARLETT CHRISTOPHER A Director · indirect
Sold, plan not stated
$68.00K 4,000 at 17.00
0.5%
17 Dec 2019
MARLETT CHRISTOPHER A Director · indirect
Sold, plan not stated
$326.11K 20,732 at 15.73
2.5%
21 Jun 2019
PASSERI DANIEL R CEO and President
Bought
$10.00K 1,377 at 7.26
2.7%
First buy on file
10 Jun 2019
Sandercock Colin SVP, General Counsel and Sec
Bought
$118.46K 14,938 at 7.93
747%
First buy on file
6 Jun 2019
PASSERI DANIEL R CEO and President
Bought
$20.70K 3,000 at 6.90
6.3%
First buy on file
6 Jun 2019
Sandercock Colin SVP, General Counsel and Sec
Bought
$14.20K 2,000 at 7.10
opened
First buy on file
31 Dec 2018
MARLETT CHRISTOPHER A Director · indirect
Bought
$85.94K 18,521 at 4.64
26.1%
First buy on file
28 Dec 2018
Bought
$32.34K 7,000 at 4.62
14.0%
First buy on file
27 Dec 2018
Bought
$95.40K 20,000 at 4.77
66.7%
First buy on file
26 Dec 2018
MARLETT CHRISTOPHER A Director · indirect
Bought
$84.29K 19,647 at 4.29
38.2%
First buy on file
Showing 1–50 of 66. Page 1 of 2 Older →